---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-157638"
form_type: "8-K"
ticker: "VOR"
cik: "0001817229"
company_name: "Vor Biopharma Inc."
filed_at: "2025-07-10T23:59:59+00:00"
generated_at: "2026-05-18T08:47:04.361055+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Vor Biopharma appoints Sandesh Mahatme as CFO and Chief Business Officer

## Summary
- Sandesh Mahatme appointed CFO, Principal Financial Officer and Principal Accounting Officer, effective July 9, 2025.
- Mahatme previously served as President, COO and CFO of National Resilience Inc., raising over $2.5B in capital.
- His initial base salary is $480,000, with a 40% target bonus and a $274,000 signing bonus.
- Received a grant of 13,882,750 RSUs under the 2023 Inducement Plan; severance includes 12–18 months base salary.
- Mahatme also joins as Chief Business Officer, bringing experience from Sarepta and Celgene.

## SEC filing metadata
- accession: 0001193125-25-157638
- form_type: 8-K
- ticker: VOR
- cik: 0001817229
- company_name: Vor Biopharma Inc.
- filed_at: 2025-07-10T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817229/000119312525157638/0001193125-25-157638-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817229/000119312525157638/d933755d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-157638
- JSON: https://secwatch.observer/filing/0001193125-25-157638.json
- Plain text: https://secwatch.observer/filing/0001193125-25-157638.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.